Annual Current Liabilities
$6.82 M
+$2.00 M+41.42%
December 31, 2023
Summary
- As of February 18, 2025, MBRX annual total current liabilities is $6.82 million, with the most recent change of +$2.00 million (+41.42%) on December 31, 2023.
- During the last 3 years, MBRX annual current liabilities has risen by +$3.90 million (+133.39%).
- MBRX annual current liabilities is now at all-time high.
Performance
MBRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$5.59 M
-$153.00 K-2.66%
September 30, 2024
Summary
- As of February 18, 2025, MBRX quarterly total current liabilities is $5.59 million, with the most recent change of -$153.00 thousand (-2.66%) on September 30, 2024.
- Over the past year, MBRX quarterly current liabilities has stayed the same.
- MBRX quarterly current liabilities is now -49.70% below its all-time high of $11.12 million, reached on September 30, 2019.
Performance
MBRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MBRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.4% | 0.0% |
| 3 y3 years | +133.4% | -14.7% |
| 5 y5 years | +75.7% | -14.7% |
MBRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +88.2% | -17.9% | +54.4% |
| 5 y | 5-year | at high | +133.4% | -17.9% | +91.5% |
| alltime | all time | at high | +781.9% | -49.7% | +471.9% |
Moleculin Biotech Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.59 M(-2.7%) |
| Jun 2024 | - | $5.75 M(+6.3%) |
| Mar 2024 | - | $5.41 M(-20.6%) |
| Dec 2023 | $6.82 M(+41.4%) | $6.82 M(+75.3%) |
| Sep 2023 | - | $3.89 M(-40.7%) |
| Jun 2023 | - | $6.55 M(+30.2%) |
| Mar 2023 | - | $5.03 M(+4.4%) |
| Dec 2022 | $4.82 M(+33.0%) | $4.82 M(-24.3%) |
| Sep 2022 | - | $6.36 M(+8.6%) |
| Jun 2022 | - | $5.86 M(+21.2%) |
| Mar 2022 | - | $4.83 M(+33.5%) |
| Dec 2021 | $3.62 M(+24.0%) | $3.62 M(-0.9%) |
| Sep 2021 | - | $3.66 M(+9.1%) |
| Jun 2021 | - | $3.35 M(-26.8%) |
| Mar 2021 | - | $4.58 M(+56.8%) |
| Dec 2020 | $2.92 M | $2.92 M(-15.1%) |
| Sep 2020 | - | $3.44 M(-8.1%) |
| Jun 2020 | - | $3.74 M(+15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.23 M(-9.4%) |
| Dec 2019 | $3.57 M(-7.9%) | $3.57 M(-67.9%) |
| Sep 2019 | - | $11.12 M(+15.9%) |
| Jun 2019 | - | $9.59 M(+49.0%) |
| Mar 2019 | - | $6.44 M(+66.0%) |
| Dec 2018 | $3.88 M(+75.1%) | $3.88 M(+23.9%) |
| Sep 2018 | - | $3.13 M(-24.0%) |
| Jun 2018 | - | $4.12 M(+128.8%) |
| Mar 2018 | - | $1.80 M(-18.8%) |
| Dec 2017 | $2.21 M(+64.7%) | $2.21 M(+20.9%) |
| Sep 2017 | - | $1.83 M(+0.1%) |
| Jun 2017 | - | $1.83 M(-17.0%) |
| Mar 2017 | - | $2.20 M(+63.9%) |
| Dec 2016 | $1.34 M(+74.0%) | $1.34 M(+5.1%) |
| Sep 2016 | - | $1.28 M(-8.7%) |
| Jun 2016 | - | $1.40 M(+43.4%) |
| Mar 2016 | - | $978.00 K |
| Dec 2015 | $772.80 K | - |
FAQ
- What is Moleculin Biotech annual total current liabilities?
- What is the all time high annual current liabilities for Moleculin Biotech?
- What is Moleculin Biotech annual current liabilities year-on-year change?
- What is Moleculin Biotech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Moleculin Biotech?
- What is Moleculin Biotech quarterly current liabilities year-on-year change?
What is Moleculin Biotech annual total current liabilities?
The current annual current liabilities of MBRX is $6.82 M
What is the all time high annual current liabilities for Moleculin Biotech?
Moleculin Biotech all-time high annual total current liabilities is $6.82 M
What is Moleculin Biotech annual current liabilities year-on-year change?
Over the past year, MBRX annual total current liabilities has changed by +$2.00 M (+41.42%)
What is Moleculin Biotech quarterly total current liabilities?
The current quarterly current liabilities of MBRX is $5.59 M
What is the all time high quarterly current liabilities for Moleculin Biotech?
Moleculin Biotech all-time high quarterly total current liabilities is $11.12 M
What is Moleculin Biotech quarterly current liabilities year-on-year change?
Over the past year, MBRX quarterly total current liabilities has changed by $0.00 (0.00%)